Logo
StreamLex Home
Logo
StreamLex Home
Laws
Laws
Recitals
Recitals
Contact
About UsNewsRecitalsTrackersNewsletterTerms of UsePrivacy NoticeLinkedIn
EHDS
  • Data & Privacy

    • Data Act
    • Data Governance Act
    • EHDS
    • ePrivacy Directive
    • GDPR
  • AI & Trust

    • Artificial Intelligence Act
    • Product Liability Directive
  • Cybersecurity

    • Cyber Resilience Act
    • Cybersecurity Act
    • DORA
    • NIS2
  • Digital Services & Media

    • Digital Markets Act
    • Digital Services Act
    • European Media Freedom Act
EHDS

EHDS Article 51. Minimum categories of electronic health data for secondary use

  • 1.
    Health data holders shall make the following categories of electronic health data available for secondary use in accordance with this Chapter:
    • (a)
      electronic health data from EHRs;
    • (b)
      data on factors impacting on health, including socioeconomic, environmental and behavioural determinants of health;
    • (c)
      aggregated data on healthcare needs, resources allocated to healthcare, the provision of and access to healthcare, healthcare expenditure and financing;
    • (d)
      data on pathogens that impact human health;
    • (e)
      healthcare-related administrative data, including on dispensations, reimbursement claims and reimbursements;
    • (f)
      human genetic, epigenomic and genomic data;
    • (g)
      other human molecular data such as proteomic, transcriptomic, metabolomic, lipidomic and other omic data;
    • (h)
      personal electronic health data automatically generated through medical devices;
    • (i)
      data from wellness applications;
    • (j)
      data on professional status, and on the specialisation and institution of health professionals involved in the treatment of a natural person;
    • (k)
      data from population-based health data registries such as public health registries;
    • (l)
      data from medical registries and mortality registries;
    • (m)
      data from clinical trials, clinical studies, clinical investigations and performance studies subject to Regulation (EU) No 536/2014, Regulation (EU) 2024/1938 of the European Parliament and of the Council , Regulation (EU) 2017/745 and Regulation (EU) 2017/746;
    • (n)
      other health data from medical devices;
    • (o)
      data from registries for medicinal products and medical devices;
    • (p)
      data from research cohorts, questionnaires and surveys related to health, after the first publication of the related results;
    • (q)
      health data from biobanks and associated databases.
  • 2.
    Member States may provide in their national law that additional categories of electronic health data are to be made available for secondary use pursuant to this Regulation.
  • 3.
    Member States may establish rules for the processing and use of electronic health data containing improvements related to the processing of those data, such as correction, annotation or enrichment, based on a data permit pursuant to Article 68.
  • 4.
    Member States may introduce stricter measures and additional safeguards at national level aimed at safeguarding the sensitivity and value of the data that fall under paragraph 1, points (f), (g), (i) and (q). Member States shall notify the Commission of those measures and safeguards and, without delay, of any subsequent amendment affecting them.

Relevant Recitals for this Article

Resources for this Article

© 2025 StreamLex

NewsletterAbout UsTerms of UsePrivacy NoticeManage cookies

© 2025 StreamLex